相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients
Takao Watanabe et al.
HEPATOLOGY INTERNATIONAL (2016)
Significant Reduction in End-Stage Liver Diseases Burden Through the National Viral Hepatitis Therapy Program in Taiwan
Chun-Ju Chiang et al.
HEPATOLOGY (2015)
Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load
Dong Hyun Sinn et al.
HEPATOLOGY (2015)
Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: A need for surveillance
Gi-Ae Kim et al.
JOURNAL OF HEPATOLOGY (2015)
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians
Pauline Arends et al.
GUT (2015)
Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort
G. V. Papatheodoridis et al.
JOURNAL OF VIRAL HEPATITIS (2015)
The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy
C. S. Coffin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population
Stuart C. Gordon et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B-A Nationwide Cohort Study
Chun-Ying Wu et al.
GASTROENTEROLOGY (2014)
Entecavir Treatment Reduces Hepatic Events and Deaths in Chronic Hepatitis B Patients With Liver Cirrhosis
Grace Lai-Hung Wong et al.
HEPATOLOGY (2013)
Long-Term Entecavir Treatment Reduces Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection
Tetsuya Hosaka et al.
HEPATOLOGY (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy
Il Han Song et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
Hashem B. El-Serag
GASTROENTEROLOGY (2012)
Assessing long-term treatment efficacy in chronic hepatitis B and C: Between evidence and common sense
Alessio Aghemo et al.
JOURNAL OF HEPATOLOGY (2012)
Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy
Cheng-Yuan Peng et al.
JOURNAL OF HEPATOLOGY (2012)
Natural history of chronic hepatitis B: what exactly has REVEAL Revealed?
Uchenna H. Iloeje et al.
LIVER INTERNATIONAL (2012)
Effectiveness of HBV Vaccination in Infants and Prediction of HBV Prevalence Trend under New Vaccination Plan: Findings of a Large-Scale Investigation
Shi-gui Yang et al.
PLOS ONE (2012)
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)